Insights from Bayer’s $1.5 Billion VC Fund | Lucio Iannone, Head of Health Venture Investments (VP) at Leaps by Bayer
Longevity for Investors with Dr. Greg Bailey and Jess Larsen
00:00
Importance of Drug-Development Experience on Teams
Jess asks about valuing drug-development experience; Lucio emphasizes team execution, replacing or augmenting leadership, and staged hires like CMO and CBO.
Transcript
Play full episode
